The global breast implants market is projected to grow from USD 2.93 billion in 2025 to USD 5.62 billion by 2034, driven by rising breast cancer cases and aesthetic surgery demand, with North America leading market share and Asia Pacific expected to witness fastest growth.

The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.

Establishment Labs CEO Juan Jose Chacon Quiros sold over $300,000 worth of company stock under a pre-arranged trading plan. The company has seen recent developments, including an expected FDA clearance for its Motiva implants and revenue growth, but also faces challenges with profitability.

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

5 analysts have expressed a variety of opinions on Establishment Labs Hldgs (NASDAQ:ESTA) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $59.6, a high estimate of $65.00, and a low estimate of $53.00. This current average reflects an increase of 16.86% from the previous average price target of $51.00. Deciphering Analyst Ratings: An In-Depth Analysis A comprehensive examination of how financial experts perceive Establishment Labs Hldgs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Joanne Wuensch Citigroup Maintains Neutral $60.00 $60.00 Joanne Wuensch Citigroup Raises Buy $60.00 $49.00 Anthony Petrone Mizuho Raises Buy $65.00 $50.00 Joshua Jennings TD Cowen Raises Outperform $60.00 $50.00 Allen Gong JP Morgan Raises Overweight $53.00 $46.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information ...Full story available on Benzinga.com

Establishment Labs (ESTA) delivered earnings and revenue surprises of 10.77% and 4.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

In the preceding three months, 4 analysts have released ratings for Establishment Labs Hldgs (NASDAQ:ESTA), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 0 0 0 Analysts have recently evaluated Establishment Labs Hldgs and provided 12-month price targets. The average target is $56.25, accompanied by a high estimate of $65.00 and a low estimate of $47.00. Witnessing a positive shift, the current average has risen by 15.57% from the previous average price target of $48.67. Investigating Analyst Ratings: An Elaborate Study In examining recent analyst actions, we gain insights into how financial experts perceive Establishment Labs Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Anthony Petrone Mizuho Raises Buy $65.00 $50.00 Joshua Jennings TD Cowen Raises Outperform $60.00 $50.00 Allen Gong JP Morgan Raises Overweight $53.00 $46.00 George Sellers Stephens & Co. Maintains Overweight $47.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information provides a snapshot ...Full story available on Benzinga.com

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million. Butterfly Network shares dipped 21.7% to $1.1588 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of compounds. Societal CDMO, Inc. (NASDAQ: SCTL) shares climbed 132.7% to $1.07 as the company agreed to be acquired by CoreRx, Inc. Volcon, Inc. (NASDAQ: VLCN) gained 55.4% to $1.8802 after surging around 39% on Wednesday. Sidus Space, Inc. (NASDAQ: SIDU) climbed 39.7% to $7.78. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 36.4% to $2.1008. Ocean Biomedical announced joint venture partner, Virion Therapeutics to present clinical study data at 2024 APASL Global Liver Meeting. Inseego Corp. (NASDAQ: INSG) rose 34.5% to $3.00. Vertex, Inc. (NASDAQ: VERX) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance. iHeartMedia, Inc. (NASDAQ: IHRT) rose 29.1% to $2.93 following fourth-quarter results. Agrify Corporation (NASDAQ: AGFY) gained 27% to $0.6161. Agrify announced a $3.4 million sales order from New Jersey woman-owned business HarvestWorks Farm. Renalytix Plc (NASDAQ: RNLX) climbed 26.5% to $1.05 after the company announced that effective Mar. 1, the US approved adding the company's kidneyintelX.dkd to its 10-year Governmentwide Acquisition Contract. Tutor Perini Corporation (NYSE: TPC) gained 26% to $11.64 following fourth-quarter results. Bright Scholar Education Holdings Limited (NYSE: BEDU) gained 25.3% to $2.3178. C3.ai, Inc. (NYSE: AI) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results. Sterling Check Corp. (NASDAQ: STER) jumped 24.6% to $15.49 after the company agreed to be acquired by First Advantage for approximately $2.2 billion, including outstanding debt. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 24% to $2.00. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Revance Therapeutics, Inc. (NASDAQ: RVNC) jumped 24% to $7.02 after the company reported better-than-expected quarterly financial results. Latham Group, Inc. (NASDAQ: SWIM) climbed 22.8% to $3.36. Avidity Biosciences, Inc. (NASDAQ: RNA) jumped 22.5% to $18.70. Avidity Biosciences announced an oversubscribed $400 million private placement. Pure Storage, Inc. (NYSE: PSTG) rose 21.9% to $51.35 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. ...

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Shares of Hormel Foods Corporation (NYSE: HRL) rose sharply during Thursday’s session after the company reported better-than-expected first-quarter earnings and reaffirmed FY24 outlook. The company reported first-quarter adjusted earnings per share of 41 cents, beating the analyst consensus of 34 cents. Quarterly revenues of $2.997 billion, beating the analyst consensus of $2.917 billion. Hormel Foods shares climbed 12.6% to $34.72 on Thursday. Here are some other big stocks recording gains in today’s session. Vertex, Inc. (NASDAQ: VERX) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance. Tutor Perini Corporation (NYSE: TPC) gained 26% to $11.64 following fourth-quarter results. C3.ai, Inc. (NYSE: AI) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results. Sterling Check Corp. ...

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 16.84% and 0.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesday’s session after the company reported better-than-expected first-quarter earnings. Acuity Brands reported a first-quarter FY24 net sales decline of 9% year-over-year to $934.7 million, marginally missing the consensus of $935.1 million. Adjusted EPS of $3.72 beat the consensus of $3.23. Acuity Brands shares jumped 10.2% to $225.51 on Tuesday. Here are some other big stocks recording gains in today’s session. Juniper Networks, Inc. (NYSE: JNPR) shares gained 21.5% to $36.71. Hewlett Packard Enterprise Co (NYSE: HPE) is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks. Accolade, Inc. (NASDAQ: ACCD) jumped 17.2% to $13.61 following third-quarter results. Century Aluminum Company (NASDAQ: